Loading…
Based on limited metadata, Swabplus, L.P. received an FDA Warning Letter on October 31, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. Further review of the complete warning letter would be necessary to identify the specific compliance issues cited.